Study targeting inflammation in people with obesity and high blood pressure
Treatments studied
Part of Hormones & metabolism clinical trials.
This Phase 1 study looks at a treatment aimed at reducing “inflammation patterns” that are common in obesity and insulin resistance. If you meet specific health and lab criteria, you may be asked to visit a research lab and provide blood samples to see how the treatment affects your body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 to 79.
- Your body mass index (BMI) is over 30.
- Your blood pressure is higher than 130/80.
- Your insulin resistance test is elevated (HOMA-IR over 2.5).
- Your waist is above the cutoff (over 102 cm for men, over 88 cm for women).
- You meet blood test limits: fasting glucose under 126 mg/dL and HbA1c under 6.5% (and triglycerides under 250 mg/dL).
- You are willing to visit the research lab (Fairway CTSU) and get blood drawn, and you can give written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how insulin affects blood vessels in people with obesity compared to healthy weight adults. It may help understand why obesity increases heart disease risk.
This early-phase study looks at how the body’s “fight-or-flight” signals may be involved in weight gain (obesity) and high blood pressure. It may help researchers understand the biology and guide future treatments.
This Phase 1 study tests how a medication that affects the body’s angiotensin system (angiotensin-(1-7)) changes metabolism in adults with obesity, insulin resistance, and high blood pressure. It may help researchers understand whether this approach can improve blood sugar/insulin function and related body changes.
This study tests whether clazakizumab can reduce the risk of heart attacks or strokes in people with high levels of inflammation (measured by a blood test called hsCRP) and conditions like heart disease, obesity, diabetes, high blood pressure, or kidney disease. If you qualify, you'll receive either the study drug or a placebo to see if it helps lower your risk.
This trial looks at how weight loss changes tiny particles released from fat cells and whether that improves blood vessel function. It may help understand how losing weight can protect your heart.
This study looks at how insulin affects blood vessels in people with obesity compared to healthy weight adults. It aims to understand early blood vessel changes that may lead to heart problems, which could help improve prevention and treatment.
Hear when a new Blood Pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.